Several New Biotech ER Openings Popping Up

Seeing a lot come through for openings. Is biotech back? Seems funding hasn’t picked up since Q1 24 - what’s going on?

TD Cowen, Leerink, LifeSci, Jefferies, Citi, Blair, as some I’ve seen recently.

410 WSO Academy Equity Research Session Reviews: 4.84/5

Springfield College

Class of '29 Sep 2026 Cohort

5.00/5

Equity Research Mock Coffee Chat

“Michael gave me very practical, specific advice for breaking into equity research as a freshman. I came in with mixed results from past alumni and industry chats, and he showed me how to make them more useful. He advised tailoring the length and questions of each chat to the contact: start with a brief intro, then pivot to targeted questions tied to their role. For shorter calls, he suggested pinpoint questions that draw out actionable advice. When a contact works in a different area, he told me to phrase my interest broadly and then ask for insight into their team or function, so my goals line up with their work. He also changed how I prepare. He told me to read the analyst’s published reports or their firm’s research before the call and to bring one or two stock or sector ideas and ask for their take, which shows I’ve done my homework. He suggested using school resources like terminals and the finance club to gather sources and data. On building my resume, he recommended continuing to publish on a Substack or website, pursuing WSO or part-time research projects, and applying to the WSO equity research internship or similar programs, then adding the published pieces to my resume and portfolio. He also told me to join my school finance club and get Bloomberg access. Finally, he coached me to ask for introductions during the call when it comes up, to repeat the request in the thank-you email, and to explicitly ask who they’d recommend and offer to follow up. I left with clear action items I can start on right away.”

Class of '25 Nov 2026 Cohort

5.00/5

Equity Research Career Roadmap (optional)

“Chris was very easy to talk to and made the session feel relaxed and genuinely useful. He gave me clear, actionable tasks that I can go away and work on straight away to expand my network. I hope to reconvene with him at a later date to discuss the progress I have made and get his feedback on the work I have been doing.”

See All 11,626 WSO Academy Reviews

3 Comments

WSO Monkey Bot

O

2y

Based on the most helpful WSO content, here's what you need to know:

Current State of Biotech ER Openings

Increased Openings: There has been a noticeable increase in biotech equity research (ER) openings at firms like TD Cowen, Leerink, LifeSci, Jefferies, Citi, and Blair.
Market Dynamics: Despite the uptick in job openings, funding in the biotech sector has not significantly picked up since Q1 2024. This suggests that while there is interest in expanding research capabilities, the overall funding environment remains cautious.

Possible Reasons for Increased Openings

Market Correction: The biotech sector has experienced a correction, which may have led to a more attractive environment for later-stage opportunities. This shift could be driving firms to bolster their research teams in anticipation of future growth.
Competitive Landscape: The biotech investing market remains highly competitive, with a focus on early-stage companies. Firms may be looking to strengthen their research teams to better navigate this competitive landscape and identify promising investment opportunities.

Industry Insights

Biotech Popularity: Biotech has become a hot sector, with investors increasingly focused on early-stage companies. This trend has led to a competitive job market, especially for those with strong scientific backgrounds.
Future Outlook: There is potential for a market correction in the coming years, which could shift the focus back to finance skills and later-stage opportunities. This could further influence hiring trends in the sector.

For more detailed discussions and insights, you can refer to the following threads on Wall Street Oasis: - https://www.wallstreetoasis.com/forum/investment-banking/qa-pharmaceuti…</a">Q&A: Pharmaceutical/Biotech Industry - https://www.wallstreetoasis.com/forum/venture-capital/biotech-finance-f…</a">Biotech finance: from IB to VC / HF to funded startup

These resources provide valuable perspectives on the current state and future outlook of the biotech industry.

Sources: Biotech finance: from IB to VC / HF to funded startup, Q&A: Pharmaceutical/Biotech Industry, Is there any part of the financial industry that is growing?, Healthcare / Biotech Venture Capital?, Divergence in the Drug Businesses: Pharmaceuticals and Biotechnology

Reply

Quote

Report

Other

I'm an AI bot trained on the most helpful WSO content across 17+ years.

ER

Associate 1 in ER

2y

Heard a few people left Jefferies… unsure about the rest

Reply

Quote

Report

Other

Authored by: Certified Equity Research Professional - 1st Year AssociateCertified Equity Research Pro

ER

Analyst 1 in ER

2y

Saepe maiores unde vel blanditiis et. Sunt eaque in totam recusandae exercitationem nostrum. Aut sit cumque tenetur culpa sit. Accusantium qui quo molestias sint eaque consequuntur sint sit. Eos ab quisquam velit quibusdam. Voluptas autem ratione alias.

Laudantium voluptatem est illum et odio voluptas. Molestiae consectetur ratione veniam enim mollitia. Autem cum dolore non eaque error in porro.

Eveniet autem dignissimos officiis quas. Dolore et autem dignissimos voluptatum. Est quidem aliquam aut eveniet in recusandae odio in.

Quia voluptatum quisquam perferendis voluptate facilis dolores. Qui consequatur alias architecto voluptatem consectetur blanditiis voluptatem. In non vel voluptatem sapiente exercitationem nesciunt ducimus sapiente. Optio eum repudiandae fuga quidem sequi est et.

Reply

Quote

Report

Other

Authored by: Certified Equity Research Professional - 1st Year AnalystCertified Equity Research Pro

+13	Is Equity Research Dying - Where Are the Future Opportunites?	4	4d
+10	Associates who stuck around for > 5 years working for the same analyst. Why?	4	1w
+9	Detailed Revenue and Cost Builds	3	1w
+7	Analyst with no coverage or ranking	5	1w
+6	Preparation for grad scheme - buyside ER	1	1d
+1	IB SA -> ER FT	4	2w
0	Equity Research Rankings	1	1w

1	redever	99.2
2	BankonBanking	99.0
3	Secyh62	99.0
4	kanon	99.0
5	Betsy Massar	98.9
6	DrApeman	98.9
7	GameTheory	98.9
8	CompBanker	98.9
9	dosk17	98.9
10	Mimbs	98.8

Elite Career Bootcamp. Top Job Offer Guaranteed.

Elite Career Bootcamp. Top Job Offer Guaranteed.

Several New Biotech ER Openings Popping Up

Score Breakdown

Feedback

Score Breakdown